Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Itama Ranoraya Tbk's Accounts Payable for the quarter that ended in Mar. 2026 was Rp538,865 Mil.
PT Itama Ranoraya Tbk's quarterly Accounts Payable
increased
from Sep. 2025 (Rp575,801 Mil) to Dec. 2025 (Rp587,385 Mil) but then
declined
from Dec. 2025 (Rp587,385 Mil) to Mar. 2026 (Rp538,865 Mil).
PT Itama Ranoraya Tbk's annual Accounts Payable
declined
from Dec. 2023 (Rp352,913 Mil) to Dec. 2024 (Rp131,066 Mil) but then
increased
from Dec. 2024 (Rp131,066 Mil) to Dec. 2025 (Rp587,385 Mil).
PT Itama Ranoraya Tbk Accounts Payable Related Terms
PT Itama Ranoraya Tbk Accounts Payable Historical Data
* Premium members only.
The historical data trend for PT Itama Ranoraya Tbk's Accounts Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
What does a Accounts Payable of Rp538,865 Mil mean?
PT Itama Ranoraya Tbk (ISX:IRRA) has a Accounts Payable of Rp538,865 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PT Itama Ranoraya Tbk and its competitors.
Is PT Itama Ranoraya Tbk's Accounts Payable too high?
PT Itama Ranoraya Tbk's current Accounts Payable is Rp538,865 Mil. Overall, PT Itama Ranoraya Tbk has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Itama Ranoraya Tbk's Accounts Payable compare to MCK and COR?
PT Itama Ranoraya Tbk's Accounts Payable of Rp538,865 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Distribution company?
A good Accounts Payable depends on the Medical Distribution industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PT Itama Ranoraya Tbk and its competitors. PT Itama Ranoraya Tbk's current Accounts Payable is Rp538,865 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Itama Ranoraya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk (ISX:IRRA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp540.14, compared to a current price of Rp374.00 — trading 30.8% below its estimated fair value. The current Accounts Payable is Rp538,865 Mil. PT Itama Ranoraya Tbk's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For PT Itama Ranoraya Tbk (ISX:IRRA), the current Accounts Payable is Rp538,865 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Itama Ranoraya Tbk (ISX:IRRA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk stock appears to be undervalued.
The current stock price of Rp374.00 is trading 30.8% below its estimated GF Value™ of Rp540.14.
GuruFocus considers PT Itama Ranoraya Tbk to be Possible Value Trap.
Key valuation signals for ISX:IRRA:
Accounts Payable: Rp538,865 Mil
GF Value™: Rp540.14 vs. price of Rp374.00 (30.8% below fair value)
No single metric tells the full story. See the ISX:IRRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. It business segment includes Vitro Diagnostic Products, Non-Electromedical Sterile Medical Devices, Electromedical Sterile Medical Devices and Other Segments. The key revenue generating segments of the company are In Vitro Diagnostic product.
81GF Score
Get the complete analysis for ISX:IRRA
Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:IRRA has been successfully added to your 
